COVID-19 Update: Convalescent Plasma Therapy & Anticoagulation
March 17, 2021
Background: Medicine by press release has been an unfortunate reality of the COVID-19 pandemic. This is not the standard many physicians would use for medical...
Marco Torres
COVID-19 Update: Time to Let Go of Convalescent Plasma Therapy
March 7, 2021
Background: Early observational studies led to the Emergency Use Authorization (EUA) for convalescent plasma therapy (CPT) in the US in August 2020 for the treatment...
COVID-19 Update: The PlasmAr Trial – Convalescent Plasma vs Placebo
December 5, 2020
Background: Despite limited high-quality evidence, many institutions are currently using convalescent plasma therapy (CPT) in the treatment of COVID-19. The majority of the evidence for...
A COVID-19 Update that is Long Overdue
November 13, 2020
Background: There have been lots of trials sitting on my computer desktop awaiting my review, but like many of you time has been thin from...
US Expanded Access Program: Convalescent Plasma, Mortality, and COVID-19
September 24, 2020
Background: Convalescent plasma therapy (CPT) is not a novel treatment modality. It has been used in other illnesses such as SARS, MERS, and Ebola with...
Convalescent Plasma Therapy for COVID-19: Hopeful Signals of Improvement
June 6, 2020
Background: Convalescent plasma therapy is not a new or novel therapeutic option. It involves taking the plasma from patients who have recovered from an illness...